𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Association of diabetes, serum insulin, and c-peptide with gallbladder disease

✍ Scribed by Constance E. Ruhl; James E. Everhart


Book ID
102241339
Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
85 KB
Volume
31
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


An inconsistent association has been found between gallbladder disease and diabetes mellitus. We hypothesized that insulin resistance rather than diabetes status may be a primary factor involved in gallstone formation. A total of 5,653 adult participants in the third United States National Health and Nutrition Examination Survey without known diabetes underwent gallbladder ultrasonography and phlebotomy after an overnight fast for measurement of serum insulin, C-peptide, and glucose. Gallbladder disease was defined as ultrasound-documented gallstones or evidence of cholecystectomy. Subjects were characterized as having normal fasting glucose (F110 mg/dL), impaired fasting glucose (110 to F126 mg/dL), or undiagnosed diabetes (H126 mg/dL). After controlling for other known gallbladder disease risk factors, among women, undiagnosed diabetes was associated with increased risk of gallbladder disease (prevalence ratio [PR] ‫؍‬ 1.91, 95% confidence interval [CI] ‫؍‬ 1.29-2.83); whereas impaired fasting glucose was unassociated. Gallbladder disease risk in women increased with levels of fasting insulin (PR ‫؍‬ 1.63, 95% CI ‫؍‬ 1.11-2.40) and C-peptide (PR ‫؍‬ 2.07, 95% CI ‫؍‬ 1.32-3.25) comparing highest to lowest quintiles. However, the association of gallbladder disease with undiagnosed diabetes was not diminished when the model included fasting insulin (PR ‫؍‬ 1.85, 95% CI ‫؍‬ 1.24-2.77). In men, there was a statistically nonsignificant association with undiagnosed diabetes (PR ‫؍‬ 2.11, 95% CI ‫؍‬ 0.76-5.85), but no association of gallbladder disease with insulin or C-peptide. Among women higher fasting serum insulin levels increased the risk of gallbladder disease, but did not account for the increased risk in persons with diabetes. (HEPATOLOGY 2000;31:299-303.) Gallbladder disease is a common condition affecting more than 20 million persons in the United States. 1 Despite its PATIENTS AND METHODS


πŸ“œ SIMILAR VOLUMES


C-peptide and Insulin in Liver Disease
✍ Johnston, D. G.; Alberti, K. G. M. M.; Wright, R.; Smith-Laing, G.; Stewart, A. πŸ“‚ Article πŸ“… 1978 πŸ› American Diabetes Association 🌐 English βš– 611 KB